Transfemoral versus transcarotid access for transcatheter aortic valve replacement.
EuroSCORE II, European System for Cardiac Operative Risk Evaluation II
Fr, French
TAVI
TAVR
TAVR, transcatheter aortic valve replacement
TC, transcarotid
TF, transfemoral
aortic stenosis
carotid artery
transcatheter aortic valve replacement
Journal
JTCVS techniques
ISSN: 2666-2507
Titre abrégé: JTCVS Tech
Pays: United States
ID NLM: 101768546
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
20
10
2020
revised:
09
02
2022
accepted:
03
03
2022
entrez:
24
10
2022
pubmed:
25
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
To compare the outcomes after transcatheter aortic valve replacement (TAVR) through a transfemoral (TF) and transcarotid (TC) access at our institution. From January 2014 to January 2020, 62 TC-TAVR and 449 TF-TAVR were performed using 2 prosthesis devices (Edwards SAPIEN 3, n = 369; Medtronic Evolut R, n = 142). Propensity score matching was used to adjust for imbalance in the baseline characteristics of the study groups. Propensity score matching provided 62 matched pairs with comparable operative risk (mean European System for Cardiac Operative Risk Evaluation II, TC-TAVR 7.6% vs TF-TAVR 6.6%, TC access for TAVR was associated with satisfactory results compared to the femoral access. TC-TAVR could be considered a valid and safe alternative to TF-TAVR when femoral access is contraindicated.
Identifiants
pubmed: 36276673
doi: 10.1016/j.xjtc.2022.05.019
pii: S2666-2507(22)00372-8
pmc: PMC9579710
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46-53Investigateurs
Laurent Faroux
(L)
Salvatore Muccio
(S)
Pierre-Frédéric Torossian
(PF)
Sébastien Duval
(S)
Li Liu
(L)
Emmanuelle Durand
(E)
Sophie Tassan
(S)
Virginie Heroguelle
(V)
Informations de copyright
© 2022 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.
Références
Eur Heart J. 2011 Jan;32(2):191-7
pubmed: 20843959
N Engl J Med. 2012 May 3;366(18):1705-15
pubmed: 22551129
JACC Cardiovasc Interv. 2019 Mar 11;12(5):413-419
pubmed: 30772290
Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1140-1146
pubmed: 31365061
Ann Thorac Surg. 2020 Jan;109(1):49-56
pubmed: 31279787
Eur J Cardiothorac Surg. 2014 Oct;46(4):693-8; discussion 698
pubmed: 24431170
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
N Engl J Med. 2017 Jul 13;377(2):197-198
pubmed: 28700842
J Am Coll Cardiol. 2007 Jul 3;50(1):69-76
pubmed: 17601548
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
EuroIntervention. 2018 Sep 20;14(7):750-757
pubmed: 29969427
Circ Cardiovasc Interv. 2018 Nov;11(11):e006388
pubmed: 30571205
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Int J Cardiol. 2016 Sep 15;219:41-55
pubmed: 27281576
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2113-2120
pubmed: 27765304
JACC Cardiovasc Interv. 2016 Mar 14;9(5):472-80
pubmed: 26965937
Ann Thorac Surg. 2017 Aug;104(2):621-629
pubmed: 28274520
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Clin Res Cardiol. 2012 Jan;101(1):45-53
pubmed: 21931964
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):903-7
pubmed: 24399743
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):157-161
pubmed: 28977565
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E583-6
pubmed: 22887932
Eur Heart J. 2018 Jan 14;39(3):213-260
pubmed: 28886622
JACC Cardiovasc Interv. 2016 Nov 28;9(22):2320-2325
pubmed: 27884356
Ann Thorac Surg. 2012 May;93(5):1489-94
pubmed: 22464036
J Am Coll Cardiol. 2017 Jul 4;70(1):42-55
pubmed: 28662806
J Am Coll Cardiol. 2012 Sep 18;60(12):1043-52
pubmed: 22883632
J Thorac Dis. 2017 May;9(Suppl 6):S478-S487
pubmed: 28616344
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275
pubmed: 27751237
Ann Thorac Surg. 2017 Mar;103(3):1021-1035
pubmed: 27955994
J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23
pubmed: 23084102